| Literature DB >> 35052902 |
Francesca Paola Nocera1, Elena D'Eletto1, Monica Ambrosio1, Filomena Fiorito1, Ugo Pagnini1, Luisa De Martino1,2.
Abstract
Streptococcus equi subsp. zooepidemicus (S. zooepidemicus), is a β-hemolytic Streptococcus belonging to the Lancefield group C; it is a rare human pathogen, but in horses, it is frequently associated with endometritis. This study aimed to isolate S. zooepidemicus strains, associated with bacterial endometritis in mares, and to define their antimicrobial resistance profile. Twenty-three isolates were recovered from one hundred ninety-six equine uterine swabs (11.7%). Bacterial identification was carried out by Api 20 Strep and confirmed by matrix assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF-MS), while antimicrobial susceptibility testing was performed by disk diffusion method on Muller Hinton agar plates. The antibiotic resistance profiles of the isolates revealed a high percentage of resistance to amikacin (95.6%), ampicillin (73.9%) and tetracycline (69.6%), while ceftiofur and ceftriaxone were highly effective with 82.6% and 78.3% of the isolates inhibited, respectively. An intriguing value of resistance to penicillin (34.8%), which represents the first-choice antibiotic in equine S. zooepidemicus infections, was observed. Furthermore, a high prevalence of multidrug-resistant strains (82.6%) was recorded. Continuous surveillance of this potential zoonotic pathogen and an appropriate antimicrobial stewardship program with the promotion of correct use of antimicrobials, after a proper diagnosis, are needed to allow an effective therapy.Entities:
Keywords: Streptococcus equi subsp. zooepidemicus; antibiotic resistance; endometritis; mares
Year: 2021 PMID: 35052902 PMCID: PMC8773361 DOI: 10.3390/antibiotics11010025
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Api 20 Strep and MALDI-TOF-MS S. zooepidemicus identification results.
| Isolate | Api 20 Strep Identification * | MALDI-TOF- MS Identification ** |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| 4 | ||
| 5 | ||
| 6 | ||
| 7 | ||
| 8 | ||
| 9 | ||
| 10 | ||
| 11 | ||
| 12 | ||
| 13 | ||
| 14 | ||
| 15 | ||
| 16 | ||
| 17 | ||
| 18 | ||
| 19 | ||
| 20 | ||
| 21 | ||
| 22 | ||
| 23 |
* Percent probabilities are reported in brackets. ** Scores are reported in brackets.
Figure 1Antibiotic resistance profiles of 23 S. zooepidemicus isolates. The isolates were classified as resistant (R), intermediate (I), or susceptible (S) to tested antibiotics. Antibiotics: AMC: amoxicillin-clavulanate; AMP: ampicillin; AK: amikacin; EFT: ceftiofur; CRO: ceftriaxone; ENR: enrofloxacin; CN: gentamicin; K: kanamycin; IMI: imipenem; MRP: meropenem; P: penicillin; S: streptomycin; SXT: sulfamethoxazole-trimethoprim; TE: tetracycline. Since 22 strains were tested to ENR, 21 to K, 22 to IMI, 22 to MRP, 20 to S, 21 to SXT and 21 to TE, a maximum error of 4.3% (1/23 × 100 = 4.3%) was considered.
Figure 2Distribution of the percentage of resistance, intermediate susceptibility, susceptibility for the tested antibiotic classes. Resistance is reported in the outermost circle, intermediate susceptibility is reported in the middle circle, susceptibility is reported in the inner circle.
Antibiotics and antibiotic classes tested for equine S. zooepidemicus isolates.
| Antibiotics | ug | Antibiotics by Class | Reference for Breakpoints |
|---|---|---|---|
| Amoxicillin-clavulanate (AMC) | 20/10 | Penicillins | [ |
| Ampicillin (AMP) | 30 | [ | |
| Penicillin (P) | 10 IU | [ | |
| Ceftiofur (EFT) | 30 | [ | |
| Ceftriaxone (CRO) | 30 | [ | |
| Amikacin (AK) | 30 | [ | |
| Gentamicin (CN) | 10 | [ | |
| Kanamycin (K) | 30 | [ | |
| Streptomycin (S) | 10 | [ | |
| Imipenem (IMI) | 10 | Carbapenems | [ |
| Meropenem (MRP) | 10 | [ | |
| Enrofloxacin (ENR) | 5 | Fluoroquinolones | [ |
| Sulfamethoxazole-trimethoprim (SXT) | 1.25/23.75 | Sulfonamides | [ |
| Tetracycline (TE) | 30 | Tetracyclines | [ |